Related Experiment Video
Updated: Jun 6, 2026
06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
C-peptide microheterogeneity in type 2 diabetes populations
Paul E Oran1, Jason W Jarvis, Chad R Borges
1The Biodesign Institute at Arizona State University, Tempe, 85287, USA.
Proteomics. Clinical Applications
|December 8, 2010
Summary
C-peptide is more diverse than previously known, with new variants identified in healthy and type 2 diabetes (T2D) populations. A specific C-peptide variant was more prevalent in T2D patients, suggesting a link to the disease.
Area of Science:
- Biochemistry
- Endocrinology
- Proteomics
Background:
- C-peptide is a biomarker for insulin production.
- Understanding C-peptide heterogeneity is crucial for diabetes research.
- Previous studies have not fully characterized C-peptide variants.
Purpose of the Study:
- To investigate naturally occurring C-peptide microheterogeneity.
- To compare C-peptide variants in healthy and type 2 diabetes (T2D) populations.
Main Methods:
- Utilized mass spectrometry (MS) immunoassays.
- Simultaneously detected intact C-peptide and variant forms.
- Analyzed plasma samples from 48 healthy and 48 T2D individuals.
Main Results:
- Identified three previously unreported C-peptide variations.
- Found one variant, C-peptide (3-31), to be more abundant in the T2D population.
- Suspected dipeptidyl peptidase IV involvement in C-peptide (3-31) formation, aligning with T2D pathophysiology.
Conclusions:
- C-peptide exists as multiple molecular species, not a single form.
- C-peptide exhibits greater qualitative heterogeneity than previously understood.
- Results provide a basis for further research into C-peptide variants in health and diabetes.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...